Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)
Clinical trial NCT03591133 · COMPLETED
Trial details
- NCT number
- NCT03591133
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-24
- Primary completion
- 2016-04-14
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.